13,992 Shares in Grail, Inc. (NASDAQ:GRAL) Purchased by Alliancebernstein L.P.

Alliancebernstein L.P. bought a new stake in shares of Grail, Inc. (NASDAQ:GRAL) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 13,992 shares of the company’s stock, valued at approximately $250,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. FNY Investment Advisers LLC bought a new stake in Grail during the 4th quarter worth approximately $26,000. Lindbrook Capital LLC purchased a new stake in shares of Grail in the fourth quarter worth $28,000. Wellington Shields Capital Management LLC bought a new stake in Grail during the fourth quarter valued at $33,000. New York State Common Retirement Fund purchased a new position in Grail during the fourth quarter worth about $59,000. Finally, Wilmington Savings Fund Society FSB bought a new position in Grail in the 4th quarter worth about $64,000.

Analyst Ratings Changes

Several brokerages have recently commented on GRAL. Morgan Stanley boosted their price objective on Grail from $16.00 to $20.00 and gave the stock an “equal weight” rating in a report on Tuesday, March 18th. Canaccord Genuity Group started coverage on shares of Grail in a report on Monday. They issued a “buy” rating and a $32.00 price target on the stock.

Insider Activity

In related news, CFO Aaron Freidin sold 1,816 shares of the company’s stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $56,659.20. Following the completion of the sale, the chief financial officer now directly owns 335,170 shares in the company, valued at $10,457,304. This represents a 0.54 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CEO Robert P. Ragusa sold 7,625 shares of the firm’s stock in a transaction on Friday, March 7th. The stock was sold at an average price of $31.21, for a total transaction of $237,976.25. Following the completion of the sale, the chief executive officer now directly owns 828,662 shares in the company, valued at approximately $25,862,541.02. This trade represents a 0.91 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,550 shares of company stock valued at $360,436.

Grail Stock Performance

NASDAQ:GRAL opened at $26.42 on Tuesday. Grail, Inc. has a 1-year low of $12.33 and a 1-year high of $63.99. The business has a 50 day moving average of $32.57 and a 200 day moving average of $23.81.

Grail (NASDAQ:GRAL) last announced its quarterly earnings data on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($4.41) by $2.55. The business had revenue of $38.25 million during the quarter, compared to analysts’ expectations of $35.33 million. Equities analysts predict that Grail, Inc. will post -15.15 EPS for the current year.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.